Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationNote: All Grants Are U.S. Funded Through 2018
Children's Cancer Institute - $143,884 USD / $190,718 AUD (Approx)
$143,884.00 USD
September 2016
Radiosensitisation of Diffuse Intrinsic Pontine Gliomas by modulating the glucose metabolism
Dana-Farber Cancer Institute - $100,000
$100,000.00 USD
December 2015
Characterizing resistance mechanisms to radiation therapy and adjuvant chemotherapy in Diffuse Intrinsic Pontine Glioma
Cincinnati Children's Hospital Medical Center - $100,000
$100,000.00 USD
December 2015
An early Phase 2 Study of LEE011, a CDK4/6 Inhibitor, following radiation therapy in Children with Newly Diagnosed non-biopsied Diffuse Pontine Gliomas (DIPG) and Rb+ biopsied DIPG and High Grade Gliomas (HGG)
Baylor College of Medicine/Texas Children's Hospital - $200,000
$200,000.00 USD
December 2015
Targeting DIPGs through Super-activation of Steroid Receptor Co-activators: An in vivo Study in Patient-derived Intra-brain Stem Xenograft Mouse Models
Children's National Health System and Children's Research Institute - $125,000
$125,000.00 USD
December 2015
Comprehensive Molecular-Based Cross-Species Comparison of DIPG Biology
Boston Children's Hospital - $110,000
$110,000.00 USD
December 2015
Enabling epigenetic therapies by exploring DIPG chromatin sensitivities
UCL Institute of Child Health - $200,000
$200,000.00 USD
December 2015
T-cell based immunotherapy for DIPG.
Dana Farber Cancer Institute - $82,863
$82,863.00 USD
December 2015
Discovering novel epigenetic dependencies in Diffuse Intrinsic Pontine Glioma
VU University Medical Center - $92,950
$92,950.00 USD
November 2015
Liquid Biopsies for the Monitoring of Diffuse Intrinsic Pontine Glioma.
Children's Cancer Institute - $145,341 USD / $176,778 AUD (Approx)
$145,341.00 USD
November 2015
Fenretinide, a novel agent targeting RTK/PI3K/AKT network for the treatment of Diffuse Intrinsic Pontine Glioma.
Cincinnati Children's Hospital Medical Center - $200,000
$200,000.00 USD
October 2015
Intra-tumoral heterogeneity in diffuse intrinsic pontine and midline high-grade gliomas
The Hospital for Sick Children - $190,905
$190,905.00 USD
October 2015
Mitochondrial DNA alterations and their potential as a novel therapeutic target in DIPG
Children's National Medical Center - $200,000
$200,000.00 USD
October 2015
Evaluating TORC1/2 kinase inhibition in murine and nonhuman primate (NHP) models
European DIPG Registry - $445,870.12
$445,870.00 USD
September 2015
European DIPG Registry.
Institute of Cancer Research - $99,470
$99,470.00 USD
September 2015
The Evolutionary Dynamics of Diffuse Intrinsic Pontine Glioma.